Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 3/20 | 0.73 |
| ▸ | ECE1 | P42892 | 12/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21641791 | 1.00 | ACE (0.73) | ACEECE1ALOX15ERAP2 | |
| SCHEMBL21641793 | 1.00 | ACE (0.73) | ACEECE1ALOX15ERAP2 | |
| SCHEMBL21641792 | 1.00 | ACE (0.73) | ACEECE1ALOX15ERAP2 | |
| SCHEMBL29470184 | 0.96 | ACE (0.68) | ACEECE1ALOX15ERAP2 | |
| SCHEMBL29750422 | 0.95 | ACE (0.67) | ACEECE1ALOX15ERAP2 | |
| SCHEMBL30123268 | 0.94 | ACE (0.66) | ACEECE1ALOX15ERAP2 | |
| SCHEMBL30834726 | 0.94 | ACE (0.66) | ACEECE1ERAP2 | |
| SCHEMBL30465908 | 0.93 | ACE (0.64) | ACEECE1ALOX15ERAP2 | |
| Valyltryptophan SCHEMBL150532 | 0.92 | ACE (0.75) | ACEECE1ALOX15 | |
| Valyltryptophan SCHEMBL30821897 | 0.92 | ACE (0.75) | ACEECE1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | L'OREAL (FR) | 2026-03-05 | — | — | US | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| WO-2024227437-A1 | PREPARATION OF PEPTIDE INHIBITOR OF INTERLEUKIN-23 RECEPTOR AND USE THEREOF | 西藏海思科制药有限公司 | 2024-11-07 | — | — | WO | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| CN-118460849-A | Method for recycling valuable metals of waste lithium batteries by using modified polypeptide green solution | 中南大学 | 2024-08-09 | — | — | CN | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4547337-A1 | NEW PEPTIDES AS SELECTIVE IL-23 RECEPTOR ANTAGONISTS | Sanofi (FR) | 2025-05-07 | — | — | EP | disclosed |
| WO-2024003313-A9 | NEW PEPTIDES AS SELECTIVE IL-23 RECEPTOR ANTAGONISTS | SANOFI (FR) | 2025-03-20 | — | — | WO | disclosed |
| CN-116254212-B | Preparation method and application of silk-like elastin hydrogel | 中国科学院天津工业生物技术研究所 | 2024-11-01 | — | — | CN | disclosed |
| US-20240352073-A1 | BICYCLIC PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | JANSSEN BIOTECH INC (US) | 2024-10-24 | — | — | US | disclosed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | disclosed |
| CN-116970080-B | Anti-human MFAP5 monoclonal antibody and preparation method thereof, polynucleotide molecule, expression vector and host cell | 优睿赛思(武汉)生物科技有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-112457404-B | Anti-human EGFR nano antibody and application | 暨南大学 | 2022-08-12 | — | — | CN | disclosed |
| CN-112457405-B | Anti-human EGFR nano antibody and application | 暨南大学 | 2022-08-12 | — | — | CN | disclosed |
| CN-112552402-B | Anti-human EGFR nano antibody and application | 暨南大学 | 2022-08-12 | — | — | CN | disclosed |
| WO-2022106063-A2 | COMPOSITIONS OF A BETA-HAIRPIN PEPTIDOMIMETIC AND AEROSOL DOSAGE FORMS THEREOF | POLYPHOR AG (CH) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022106063-A2 | COMPOSITIONS OF A BETA-HAIRPIN PEPTIDOMIMETIC AND AEROSOL DOSAGE FORMS THEREOF | POLYPHOR AG (CH) | 2022-05-27 | — | — | WO | disclosed |
| CN-114478789-A | anti-PD-L1 and OX40 bispecific antibodies and uses thereof | 安徽安科生物工程（集团）股份有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-110225770-B | Fibronectin type III domain binding to CD8A | 杨森生物科技公司 | 2022-04-26 | — | — | CN | disclosed |
| EP-3947743-A1 | METHODS OF DIAGNOSING DISEASE | 4D Pharma Cork Limited (IE) | 2022-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | TYR, CUTA, ARGLU1 | ACE 3524/4885ECE1 4095/4885ALOX15 532/4885 |
| US-20240352073-A1 | BICYCLIC PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | IL23R, IL1RN, IL17A | ACE 1092/4885ECE1 1508/4885ALOX15 2175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.